
PFIZER, INC.
PFE
![]() |
|
52.31USD | -0.23% |
Turn to zoom
Prev. | 52.3100 |
Open | 52.0400 |
High | 52.3700 |
Low | 51.2500 |
Volume | 16 135 661 |
Latest news
Chart PFIZER, INC.
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Neutral | Neutral | Neutral |
Resistance | 54,0 | 59,1 | 59,5 |
Spread/Res. | -3,1% | -11% | -12% |
Spread/Supp. | 14% | 14% | 26% |
Support | 45,8 | 45,8 | 41,5 |
Financials
|
|
Company
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- vaccines (52.4%);
- drugs for the treatment of cancer (15.2%);
- cardiovascular, metabolic and analgesic drugs (11.5%);
- injectable, anti-infectives drugs and active pharmaceutical...
- vaccines (52.4%);
- drugs for the treatment of cancer (15.2%);
- cardiovascular, metabolic and analgesic drugs (11.5%);
- injectable, anti-infectives drugs and active pharmaceutical...
Sector : |
Other Pharmaceuticals
|
Calendar : |
2022-07-28 Earnings Release
|
Trading Rating : |
Investor Rating : |
Income Statement Evolution
Consensus
Sell ![]() Buy |
|
Mean consensus | OUTPERFORM |
Number of Analysts | 23 |
Last Close Price | 52,31 $ |
Average target price | 57,00 $ |
Spread / Average Target | 8,97% |